Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
14 juin 2018 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., June 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Chronic and Rare Disease Groups Raise Alarm About California Bill that Threatens Access to Insurance Coverage for Kidney Patients
08 juin 2018 10h00 HE
|
American Kidney Fund
ROCKVILLE, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Thirteen groups representing patients with chronic and rare diseases have joined the American Kidney Fund and others in opposition to California...
LogistiCare and National Kidney Foundation Join to End Kidney Disease
22 mai 2018 11h29 HE
|
LogistiCare
Atlanta, GA, May 22, 2018 (GLOBE NEWSWIRE) -- The National Kidney Foundation of Georgia hosted the 2018 Atlanta Kidney Walk on Saturday, May 19 at Atlantic Station in Midtown Atlanta. Thousands of...
Proteon Therapeutics Announces First Quarter 2018 Financial Results
09 mai 2018 08h10 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply
08 mai 2018 07h00 HE
|
Proteon Therapeutics, Inc.
Partners extend existing contract for manufacture of vonapanitase to 2029 as ongoing Phase 3 trial nears completionLonza Pharma & Biotech successfully scaled up a lab process at their Microbial...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results
14 mars 2018 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
06 mars 2018 16h45 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
05 mars 2018 17h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th
08 nov. 2017 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Third Quarter 2017 Financial Results
07 nov. 2017 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...